论文信息 - LBA28 A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial - 字舞流文

LBA28 A randomised double-blind placebo-controlled phase II trial of palbociclib combined with letrozole (L) in patients (pts) with oestrogen receptor-positive (ER+) advanced/recurrent endometrial cancer (EC): NSGO-PALEO / ENGOT-EN3 trial

F. Marmé | I. Runnebaum | J. Sehouli | K. Lindemann | M. Mirza | B. Ataseven | L. Bjørge | H. Roed | F. Trillsch | M. Gil-Martin | V. Salutari | A. Auranen | R. Christensen | B. Lund | A. Redondo | M. Rubio | G. Nyvang | M. P. B. Ginesta | J. Løhndorf